CIK 0001446159 · Non-accelerated filer<br>Smaller reporting company
AXE COMPUTE INC.
Sign in to watch- Ticker
- AGPU
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 331007393
- Phone
- 305-563-3850
- Business address
- 801 BRICKELL AVENUE, SUITE 510, MIAMI, FL, 33131
- Former names
- Predictive Oncology Inc., Precision Therapeutics Inc., Skyline Medical Inc., BioDrain Medical, Inc.
- Open-market buys, last 90 days
- $98,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$98,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-09-16 | JOHNSON DAVID O. Chief Operating Officer | Grant or award · Stock Options (right to buy) | −89,339 | 89,339 | ||
| 2016-09-16 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (right to buy) | −89,339 | 89,339 | ||
| 2016-06-30 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +33,334 | 33,334 | ||
| 2016-06-30 | Schwartz Carl I. Director | Grant or award · Stock Options (right to buy) | +33,334 | 33,334 | ||
| 2016-06-30 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +33,334 | 33,334 | ||
| 2016-04-06 | Kornberg Joshua CEO and President | Conversion | +11,112 | 18,073 | ||
| 2016-04-06 | Kornberg Joshua CEO and President | Conversion · Series B Convertible Preferred Stock | +11,112 | 0 | ||
| 2016-04-06 | Kornberg Joshua CEO and President | Conversion | +2,778 | 9,739 | ||
| 2016-04-06 | Kornberg Joshua CEO and President | Conversion · Series B Convertible Preferred Stock | +2,778 | 0 | ||
| 2016-03-31 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +29,412 | 29,412 | ||
| 2016-03-31 | Kornberg Joshua CEO and President | Grant or award · Stock Option (right to buy) | +29,412 | 29,412 | ||
| 2016-03-31 | Schwartz Carl I. Director | Grant or award · Stock Options (right to buy) | +14,706 | 14,706 | ||
| 2016-03-31 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +29,412 | 29,412 | ||
| 2016-01-06 | MYERS ROBERT L Chief Financial Officer | Option exercise | +15,685 | $2.63 | $41K | 15,819 |
| 2016-01-06 | MYERS ROBERT L Chief Financial Officer | Option exercise · Stock Options (right to buy) | −15,685 | 0 | ||
| 2016-01-06 | JOHNSON DAVID O. Chief Operating Officer | Option exercise | +17,111 | $2.63 | $45K | 17,302 |
| 2016-01-06 | JOHNSON DAVID O. Chief Operating Officer | Option exercise · Stock Options (right to buy) | −17,111 | 0 | ||
| 2015-12-31 | Reding Andrew P. Director | Grant or award · Stock Option (right to buy) | +8,504 | 8,504 | ||
| 2015-12-31 | McGoldrick Thomas J. Director | Grant or award · Stock Option (right to buy) | +11,905 | 11,905 | ||
| 2015-12-31 | Kornberg Joshua CEO and President | Grant or award · Stock Option (right to buy) | +1,701 | 1,701 |
Page 19 of 20 · 384 trades